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Frutalin is the -D-galactose-binding lectin expressed in breadfruit seeds (Artocarpus incisa). 
This lectin may be used in cancer diagnostics/therapeutics due to its potential ability to 
recognise specific carbohydrates expressed in cancer cells membranes and/or cells surface 
receptors. However, frutalin extraction from plant seeds is a time-consuming process and 
typically results in a heterogeneous mixture of different natural isoforms. To overcome these 
limitations, frutalin was cloned and expressed in Pichia pastoris [1] and Escherichia coli [2]. 
Recombinant frutalin was detected in cultures of these microorganisms by SDS-PAGE and 
Western blot analysis. The higher recombinant frutalin yield was obtained in the P. pastoris 
expression system (up to 20 mg/L). Molecular and biological differences were found between 
each recombinant and native frutalin. Potential biomedical applications for native frutalin and 
recombinant frutalin produced in P. pastoris were studied. Recombinant frutalin 
demonstrated higher capacity than native frutalin to differentiate malign from benign human 
prostate diseases by immunohistochemistry (with a significant positive statistical correlation, 
P<0.00001), in spite of its lower carbohydrate-binding affinity [3]. In addition, native and 
recombinant frutalin showed an identical magnitude of cytotoxicity on HeLa cervical cancer 
cells growth (IC50=100 g/mL, 24 h), by inducing cell apoptosis and inhibiting cell proliferation 
and migration. Interaction studies conducted by confocal microscopy showed that native and 
recombinant frutalin were internalised and targeted to HeLa cell’s nucleus within 1 h of 
incubation. Therefore, frutalin with promising application in cancer diagnosis and therapy 
might be obtained from the recombinant P. pastoris expression system in alternative to its 
natural source. 
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